Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAND: LX-P vs oral loxoprofen in chronic low back pain
jRCT2080222337Phase 3
- Sponsor
- Lead Chemical
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of loxoprofen in chronic low back pain (CLBP) (2 arms), sponsored by Lead Chemical.
02
Drugs
loxoprofen
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on jRCT2080222337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222337.